STRATA Skin Sciences, Inc. ( SSKN) Stock. Should you Buy or Sell? $ 0.98
-0.02 (-2.07 %)
STRATA Skin Sciences, Inc. Analysis
Updated on 10-09-2022| Symbol | SSKN |
| Price | $0.98 |
| Beta | 1.888 |
| Volume Avg. | $85.33 thousand |
| Market Cap | $34.17 M |
| 52 Week Range | $0.92 - $1.95 |
STRATA Skin Sciences, Inc. opened the day at $0.98 which is -2.07 % on yesterday's close. STRATA Skin Sciences, Inc. has a 52 week high of $1.95 and 52 week low of $0.92, which is a difference of $1.03. We like to see positive, upward trending shares, preferably with momentum. Market capitalization is $34.17 M and total net profit is $29977000 which means the company is trading at 1.14 times profit to market capitalization. Theoretically, if you were to buy STRATA Skin Sciences, Inc. for $34.17 M, it would take 15 years to get your money back. STRATA Skin Sciences, Inc. are in the Medical Devices space which will have a sweet spot and industry standard for net profit multiples.
Price Chart
Financials
STRATA Skin Sciences, Inc. Stock Forecast - Is STRATA Skin Sciences, Inc. a Buy or Sell?
| DCF Score | Strong Buy | |
| ROE Score | Neutral | |
| ROA Score | Neutral | |
| DE Score | Buy | |
| PE Score | Strong Sell | |
| PB Score | Strong Buy | |
| Overall Recommendation | Buy |
Growth and Value
| PE Ratio | -4.503 |
| Dividend Yiel | 0.000 |
| Net Profit Margin | -0.198 |
Valuing STRATA Skin Sciences, Inc.
| Price Book Value Ratio | 1.529 | Price To Book Ratio | 1.529 |
| Price To Sales Ratio | 0.890 | Price Earnings Ratio | -4.503 |
How liquid is STRATA Skin Sciences, Inc.
| Current Ratio | 1.297 |
| Quick Ratio | 0.907 |
Debt
| Debt Ratio | 0.583 | Debt Equity Ratio | 1.399 |
| Long Term Debt To Capitalization | 0.256 | Total Debt To Capitalization | 0.261 |
Latest news about STRATA Skin Sciences, Inc.
HORSHAM, Pa., Aug. 22, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced the company will present at the upcoming Inaugural Gilmartin Group Emerging Growth Company Showcase, taking place virtually. Members of management are scheduled to present on Wednesday, August 31, 2022 at 3:30 PM ET.
STRATA Skin Sciences, Inc. (NASDAQ:SSKN ) Q2 2022 Earnings Conference Call August 10, 2022 4:30 PM ET Company Participants Leigh Salvo - Investor Relations Robert Moccia - Chief Executive Officer Christopher Lesovitz - Chief Financial Officer Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Operator Greetings ladies and gentlemen and welcome to the STRATA Skin Sciences Second Quarter of 2022 Earnings Conference Call. At this time, all participants are in listen-only mode.
Strata Skin Sciences, Inc. (SSKN) delivered earnings and revenue surprises of -25% and 12.27%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
HORSHAM, Pa., June 07, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, announced today that it will be participating in the Lytham Partners Summer 2022 Investor Conference taking place virtually on June 21-22, 2022.
STRATA Skin Sciences, Inc. (NASDAQ:SSKN ) Q1 2022 Earnings Conference Call May 11, 2022 4:30 PM ET Company Participants Leigh Salvo - Investor Relations Robert Moccia - Chief Executive Officer Christopher Lesovitz - Chief Financial Officer Conference Call Participants Destiny Alexandra Buch - Ladenburg Thalmann & Co. Inc. Suraj Kalia - Oppenheimer & Company, Inc. Operator Greetings. Welcome to the STRATA Skin Sciences First Quarter 2022 Earnings Conference Call.
About STRATA Skin Sciences, Inc.
Description :
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. Its products include XTRAC and Pharos excimer lasers, VTRAC lamp systems, and TheraClear treatment systems that are used for the treatment of psoriasis, vitiligo, acne, and other skin conditions. The company distributes its products internationally through distributors, and domestically directly to physicians. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.
